The Archive · 3 posts
Decode disease with Verici Dx (VRCI) 🔬. A innovator in renal diagnostics, shaping the future of healthcare. Dive in to discover more! 🚀
Verici Dx reports FY25 commercial progress: Tutivia tests up 250% to 1,173, Medicare coverage secured, but cash burn remains key risk.
Showing 2 of 3 posts
Verici Dx Q1 2026: Tutivia testing volumes jump 32% as adoption widens across US transplant centres and reimbursement tailwinds build. A strong start to the year.
JoshuaApril 16, 2026
Verici Dx's FY25 growth driven by first Tutivia revenues and key Medicare coverage, unlocking scalable commercial expansion.
JoshuaFebruary 5, 2026
June 29, 2026